Amalgamated Bank’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14K | Hold |
1,058
| – | – | ﹤0.01% | 2274 |
|
|
2025
Q1 | $11K | Buy |
1,058
+157
| +17% | +$1.63K | ﹤0.01% | 2322 |
|
|
2024
Q4 | $14K | Hold |
901
| – | – | ﹤0.01% | 2275 |
|
|
2024
Q3 | $52K | Hold |
901
| – | – | ﹤0.01% | 1836 |
|
|
2024
Q2 | $41K | Buy |
901
+34
| +4% | +$1.55K | ﹤0.01% | 1900 |
|
|
2024
Q1 | $57K | Sell |
867
-2,255
| -72% | -$148K | ﹤0.01% | 1834 |
|
|
2023
Q4 | $124K | Sell |
3,122
-207
| -6% | -$8.22K | ﹤0.01% | 1935 |
|
|
2023
Q3 | $106K | Hold |
3,329
| – | – | ﹤0.01% | 1974 |
|
|
2023
Q2 | $134K | Buy |
3,329
+645
| +24% | +$26K | ﹤0.01% | 1968 |
|
|
2023
Q1 | $115K | Sell |
2,684
-561
| -17% | -$24K | ﹤0.01% | 2000 |
|
|
2022
Q4 | $156K | Buy |
3,245
+439
| +16% | +$21.1K | ﹤0.01% | 1948 |
|
|
2022
Q3 | $106K | Buy |
2,806
+171
| +6% | +$6.46K | ﹤0.01% | 2124 |
|
|
2022
Q2 | $73K | Buy |
2,635
+93
| +4% | +$2.58K | ﹤0.01% | 2307 |
|
|
2022
Q1 | $138K | Buy |
+2,542
| New | +$138K | ﹤0.01% | 2078 |
|